Tigermed Successfully Completes the Acquisition of Japanese CRO Micron

Tigermed Completes Acquisition of Micron

In recent industry news, Tigermed, a prominent global provider of clinical research solutions, has successfully finalized the acquisition of Micron, a leading Contract Research Organization (CRO) based in Japan. This acquisition marks a significant step for Tigermed as it expands its footprint in the Asian market. Tigermed, listed under stock codes 300347.SZ and 3347.HK, has a robust reputation for providing comprehensive services throughout the biopharmaceutical and medical device lifecycle.

The Significance of Micron

Founded in 2005 and headquartered in Tokyo, Micron has established itself as the first imaging CRO in Japan. With a workforce exceeding 160 professionals, Micron has built a commendable reputation over nearly 20 years, catering to a diverse client base that includes over 250 companies. Micron’s expertise in medical imaging and clinical trial services is well-recognized, having played a pivotal role in the successful approval of more than 40 drugs. This unique positioning will undoubtedly improve Tigermed's capabilities in Japan and the broader Asia-Pacific region.

Micron has also been known for its technological excellence, especially in pioneering imaging biomarkers and integrating artificial intelligence in its processes. The company’s commitment to transformational innovations and its wealth of expertise will synergistically complement Tigermed’s existing operations.

Integration and Future Plans

Post-acquisition, Micron will function as a key component within Tigermed Japan, benefiting from the substantial operational infrastructure that Tigermed offers. Tigermed plans to leverage Micron’s extensive experience and specialized expertise, enhancing their medical imaging services and support for clinical trials across the Asia-Pacific region. The company aims to integrate Micron's sophisticated imaging techniques and deep regional insights into its global operational strategy, thus solidifying its competitive edge in the clinical research landscape.

Hiroaki Suzuki, the President and Co-founder of Micron, expressed excitement about joining Tigermed, highlighting the company’s commitment to enhancing human health via advanced imaging technologies. He stated, “We believe our 20 years of medical imaging experience will be a strong asset to Tigermed. Additionally, Tigermed’s global resources will provide Micron with an opportunity for broader expansion.